Shujuan B. Jiang
324 Jingwu Road
Jinan, 250021, China
Jinan, 250021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Identification and validation of parthanatos-related genes in lung adenocarcinoma and construction of a prognostic risk model.
Journal: Frontiers in immunology
Published: February 08, 2026
Heterogeneous impact of tea consumption on COPD risk in smokers: insights from the PIFCOPD study.
Journal: Frontiers in medicine
Published: December 27, 2025
The Protective Effect and Mechanism of Mild Hypothermia on Lung Injury after Cardiopulmonary Resuscitation in Pigs.
Journal: Critical reviews in immunology
Published: April 15, 2024
Safety and efficacy of inhalable ambroxol hydrochloride aerosol for adult patients with respiratory diseases: an open-label, single-arm, multicentre study.
Journal: BMJ open respiratory research
Published: September 27, 2023
Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China.
Journal: JMIR public health and surveillance
Published: March 21, 2023
Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.
Journal: Cell death & disease
Published: January 22, 2023
Ambient fine particulate matter and allergic symptoms in the middle-aged and elderly population: results from the PIFCOPD study.
Journal: Respiratory research
Published: December 27, 2022
Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors.
Journal: Frontiers in immunology
Published: November 10, 2022
Clinical Characteristics and Economic Burden of Asthma in China: A Multicenter Retrospective Study.
Journal: Iranian journal of allergy, asthma, and immunology
Published: June 24, 2022
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1low/negative non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy.
Journal: International journal of oncology
Published: November 26, 2021
Last Updated: 09/26/2026